The main aim of the guideline is to address the use of a multi-strain dossier for inactivated vaccines against antigenically variable viruses or bacteria and to provide information on criteria for eligibility to use the multi-strain approach and on data to be included in a multi-strain dossier.
Keywords: Multi-strain dossier, inactivated veterinary vaccines
Current effective version
Guideline on data requirements for multi-strain dossiers for inactivated veterinary vaccines - Revision 2
English (EN) (253.6 KB - PDF)
Questions and Answers on data requirements for multi-strain dossiers for inactivated veterinary vaccines
English (EN) (164.61 KB - PDF)
Document history - Revision 2
Guideline on data requirements for multi-strain dossiers for inactivated veterinary vaccines - Revision 2
English (EN) (253.6 KB - PDF)
Questions and Answers on data requirements for multi-strain dossiers for inactivated veterinary vaccines
English (EN) (164.61 KB - PDF)
Draft guideline on data requirements for multi-strain dossiers for inactivated veterinary vaccines
English (EN) (241.59 KB - PDF)
Overview of comments received on 'Draft revised guideline on data requirements for multi-strain dossiers for inactivated veterinary vaccines’ (EMA/CVMP/IWP/105506/2007 Rev. 2)
English (EN) (342.62 KB - PDF)
Draft concept paper for the revision of the guideline on data requirements for multi-strain dossiers for inactivated vaccines against Avian Influenza (AI), Blue Tongue (BT) and Foot and Mouth Disease (FMD) - Revision 2
English (EN) (197.18 KB - PDF)
Document history - Revision 1
Guideline on data requirements for multi-strain dossiers for inactivated vaccines against avian influenza (AI), Bluetongue (BT) and Foot-and-Mouth disease (FMD) - Revision 1
This guideline updates the ‘Guideline on data requirements for multi-strain dossiers for inactivated vaccines against avian influenza (AI), Bluetongue (BT) and Foot-and-Mouth disease (FMD)’ (EMA/CVMP/IWP/105506/2007).
English (EN) (141.8 KB - PDF)
Overview of comments received on 'Guideline on data requirements for multi-strain dossiers for inactivated vaccines against avian influenza (AI), Bluetongue (BT) and Foot-and-Mouth disease (FMD)' - Revision 1
English (EN) (119.92 KB - PDF)
Questions and answers on data requirements for multi-strain dossiers for inactivated vaccines against avian influenza (AI), Bluetongue (BT) and Foot-and-Mouth disease (FMD) - Revision 1
English (EN) (104.5 KB - PDF)
Draft guideline on data requirements for multi-strain dossiers for inactivated vaccines against avian influenza (AI), bluetongue (BT) and foot-and-mouth disease (FMD) - Revision 1
This guideline was first published in 2010 based on general scientific and regulatory principles in advance of much practical experience from assessing applications through European authorisation procedures. This revision was prepared following a review by CVMP of issues raised by stakeholders based on their experience of operating the guideline. Only minor changes were considered necessary to the guideline itself and an accompanying ‘Question and Answer’ document was produced to address the topics raised by stakeholders that are not specifically addressed within the revised guideline.
English (EN) (154.79 KB - PDF)
Concept paper for the revision of the guideline on data requirements for multi-strain dossiers for inactivated vaccines against avian influenza, blue tongue and foot and mouth disease - Revision 1
The Immunologicals Working Party recommends to review, and possibly revise, the Committee for Medicinal Products for Veterinary Use ‘Guideline on data requirements for multi-strain dossiers for inactivated vaccines against avian influenza, blue tongue and foot and mouth disease’, in order to take into account issues identified since the guideline came into effect and experience gained during assessment of recent applications for marketing authorisations. To ensure that all potential issues are covered, the IWP is relying on industry’s cooperation during the consultation period of this concept paper. It is important to identify any remaining issues not covered by the existing guideline or listed in this concept paper and the corresponding level of clarification needed.
English (EN) (85.21 KB - PDF)
Document history - First version
Questions and answers on data requirements for multi-strain dossiers for inactivated vaccines against avian influenza (AI), bluetongue (BT) and foot-and-mouth disease (FMD) - First version
English (EN) (87.54 KB - PDF)
Guideline on data requirements for multistrain dossiers for inactivated vaccines against avian influenza, bluetongue and foot-and-mouth disease - First version
English (EN) (103.38 KB - PDF)
Overview of comments received on ‘Guideline on data requirements for multi-strain dossiers for inactivated vaccines against avian influenza (AI), bluetongue (BT) and foot and mouth disease (FMD)’ - First version
Overview of comments received on ‘Guideline on data requirements for multi-strain dossiers for inactivated vaccines against avian influenza (AI), blue tongue (BT) and foot and mouth disease (FMD)’ (EMEA/CVMP/IWP/105506/2007)
English (EN) (169.71 KB - PDF)
Draft guideline on data requirements for multi-strain dossiers for inactivated vaccines against avian influenza (AI), bluetongue (BT) and foot and mouth disease (FMD) - First version
English (EN) (100.54 KB - PDF)
Concept paper on requirements for multi-strain dossiers - First version
Concept paper on requirements for multi-strain dossiers
English (EN) (30.34 KB - PDF)
Recommendation on the submission of multistrain-dossier applications for vaccines against avian influenza, bluetongue and foot-and-mouth disease
English (EN) (130.63 KB - PDF)